SKL-24741

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameSKL-24741
Drug Alias NameSKL-24741
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated sodium channels blockersVoltage-gated potassium channel agonists
TargetsVoltage-gated sodium channelsVoltage-gated potassium channel
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSk Life Science IncSpaulding Clinical Research Llc
China Registration ClassN/A

Develop Information

Active CompaniesInsignis Therapeutics IncSk Life Science Inc
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A